Experimental drug can reduce symptoms of inflammatory bowel disease in pre-clinical models

A new study of mice and lab-grown human colon “organoids” indicates that an experimental drug developed by Johns Hopkins Medicine researchers can substantially reduce symptoms of inflammatory bowel disease (IBD) in pre-clinical models.

Opinion | Medical School Should Teach Students About Homelessness

Doran is an emergency physician and a researcher on the intersection between housing and health. Last month I gave a lecture to first-year medical students

September 14, 2023

New discovery could lead to improved treatments for age- and cancer-related muscle degeneration

With the global population aging rapidly, sarcopenia, a condition that affects millions of older adults and severely diminishes their quality of life, is emerging as

September 26, 2024

FDA responds to claim breast implant removal is ‘reasonable’ to cut cancer risk

Dive Brief: The U.S. Food and Drug Administration responded to experts’ recommendations on managing cancer risks in people with breast implants. An expert panel convened by

March 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.